Response Rates of Invasive Lobular Cancer in Patients Undergoing Neoadjuvant Endocrine or Chemotherapy.
James W JakubWenexia ZhangMalvika SolankiJennifer YonkusJudy C BougheyScott HarmsenKarthik V GiridharPublished in: The American surgeon (2022)
In Her2Neu-negative ILC, the potential of a pCR with NACT or NET is low. Most patients' nodal status and tumor size remain unchanged. There is a potential for pathologic stage to be higher at surgery compared to the clinical stage prior to neoadjuvant therapy.
Keyphrases
- locally advanced
- rectal cancer
- neoadjuvant chemotherapy
- lymph node
- patients undergoing
- end stage renal disease
- newly diagnosed
- minimally invasive
- ejection fraction
- squamous cell carcinoma
- radiation therapy
- papillary thyroid
- prognostic factors
- peritoneal dialysis
- human health
- risk assessment
- patient reported outcomes
- acute coronary syndrome
- percutaneous coronary intervention
- squamous cell
- surgical site infection
- mesenchymal stem cells
- lymph node metastasis
- patient reported
- nk cells